INBX
Inhibrx Biosciences, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Inhibrx Biosciences (INBX) Stock: Buy, Sell, or Hold?
$90.61
-1.13 (-1.23%)
▼
5d:
+11.75%
30d:
+0.09%
90d:
-7.88%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 13, 2026
1d
Protect INBX Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (80%)
Quality Score
53/100
Position
FAIR
30-Day Fair Range
$80.29 – $95.72
Position: FAIR
Forward P/E & Valuation
-10.3x
Next 12M consensus est.
Wall Street Target
$266.67
+194.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$66.80 / $96.79
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: INBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When INBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INBX is currently trading at $90.61, which is considered fair relative to its 30-day fair value range of $80.29 to $95.72.
Technical Outlook: Technically, INBX is showing sideways momentum. Immediate support is located at $66.80, while resistance sits at $96.78.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $266.67 (+194.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INBX is showing sideways momentum. Immediate support is located at $66.80, while resistance sits at $96.78.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $266.67 (+194.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$80.29 -
$95.72
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
Trading Range & Key Levels
30-Day Trading Range
$80.29 -
$95.72
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$11.54
(12.7%)
Support Level
$66.80
Resistance Level
$96.79
Current Trend
Sideways
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding INBX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 194.3% below Wall St target ($266.67)
- NEUTRAL: Bottoming setup forming (57/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-10.34
Wall Street Target
$266.67
(+194.3%)
Revenue Growth (YoY)
-100.0%
Share INBX Analysis
Share this live INBX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INBX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 15, 2026
Daily AI digest
AI Retail Discussion Summary:
Inhibrx Biosciences is presenting updated data on its clinical-stage candidates INBRX-106 and INBRX-109 at major oncology conferences, bringing its clinical data into wider scrutiny.
Key Retail Themes:
clinical data presentations
further validation of HexAgon Phase 2 results
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:52 AM ET
Data refreshes hourly during market hours. Next update: 9:52 AM
Data refreshes hourly during market hours. Next update: 9:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 42 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 46 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
18 analysts |
$72 | 31 SELL |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 55 HOLD |
Advanced INBX Option Strategies
Professional options setups generated by AI based on today's INBX price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INBX Research Pages
